Studies also suggest that NAT1*10 genetic variant may be associated with elevated levels of NAT1 enzyme activity and was reported to be associated with colon cancer, and to be less frequent among studied groups of bladder cancer patients [18, 21, 22]. This evidence concerns the gene NAT1 and urinary bladder carcinoma.